Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | 5'partial|ATP binding cassette sub family B | 0.0096 | 0.0505 | 0.977 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0068 | 0.0188 | 0.3639 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0097 | 0.0517 | 1 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0097 | 0.0517 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0097 | 0.0517 | 1 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0097 | 0.0517 | 1 |
Mycobacterium tuberculosis | Probable transmembrane multidrug efflux pump | 0.0097 | 0.0517 | 0.5 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0097 | 0.0517 | 1 |
Schistosoma mansoni | multidrug resistance protein | 0.0097 | 0.0517 | 1 |
Plasmodium falciparum | multidrug resistance protein 1 | 0.0097 | 0.0517 | 1 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0068 | 0.0188 | 0.3639 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0097 | 0.0517 | 1 |
Schistosoma mansoni | multidrug resistance protein | 0.0097 | 0.0517 | 1 |
Echinococcus multilocularis | ATP binding cassette sub family B | 0.0096 | 0.0505 | 0.977 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0097 | 0.0517 | 1 |
Toxoplasma gondii | ATP-binding cassette transporter ABC.B1 | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0097 | 0.0517 | 1 |
Leishmania major | phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.0484 | 0.4853 | 1 |
Schistosoma mansoni | multidrug resistance protein | 0.0097 | 0.0517 | 1 |
Trypanosoma brucei | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0484 | 0.4853 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0097 | 0.0517 | 1 |
Onchocerca volvulus | 0.0097 | 0.0517 | 0.5 | |
Entamoeba histolytica | P-glycoprotein 5, putative | 0.0097 | 0.0517 | 0.0517 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0068 | 0.0188 | 0.3639 |
Brugia malayi | ABC transporter family protein | 0.0097 | 0.0517 | 1 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0097 | 0.0517 | 1 |
Plasmodium vivax | multidrug resistance protein 1, putative | 0.0097 | 0.0517 | 1 |
Entamoeba histolytica | P-glycoprotein-1 | 0.0097 | 0.0517 | 0.0517 |
Trichomonas vaginalis | ABC transporter, putative | 0.0097 | 0.0517 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | taga, putative | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.0097 | 0.0517 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0097 | 0.0517 | 1 |
Entamoeba histolytica | P-glyco protein 6, putative | 0.0097 | 0.0517 | 0.0517 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0097 | 0.0517 | 1 |
Trypanosoma brucei | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0484 | 0.4853 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0097 | 0.0517 | 1 |
Schistosoma mansoni | smdr2 | 0.0097 | 0.0517 | 1 |
Entamoeba histolytica | P-glycoprotein-2 | 0.0097 | 0.0517 | 0.0517 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0097 | 0.0517 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0096 | 0.0505 | 0.977 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0097 | 0.0517 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0097 | 0.0517 | 1 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0097 | 0.0517 | 1 |
Loa Loa (eye worm) | multidrug resistance protein 3 | 0.0097 | 0.0517 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0097 | 0.0517 | 1 |
Entamoeba histolytica | P-glycoprotein-2, putative | 0.0097 | 0.0517 | 0.0517 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0097 | 0.0517 | 1 |
Chlamydia trachomatis | ABC transporter ATP binding protein/permease | 0.0097 | 0.0517 | 0.5 |
Entamoeba histolytica | P-glycoprotein-5 | 0.0097 | 0.0517 | 0.0517 |
Toxoplasma gondii | ABC transporter transmembrane region domain-containing protein | 0.0097 | 0.0517 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0097 | 0.0517 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.0097 | 0.0517 | 1 |
Trypanosoma cruzi | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0484 | 0.4853 | 0.5 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0097 | 0.0517 | 1 |
Entamoeba histolytica | P-glycoprotein-2 | 0.0097 | 0.0517 | 0.0517 |
Brugia malayi | multidrug resistance protein 3 | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0097 | 0.0517 | 1 |
Trypanosoma cruzi | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0484 | 0.4853 | 0.5 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0097 | 0.0517 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0068 | 0.0188 | 0.3639 |
Trichomonas vaginalis | abcb9, putative | 0.0097 | 0.0517 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0097 | 0.0517 | 1 |
Loa Loa (eye worm) | ATP-binding cassette sub-family B member 2 | 0.0097 | 0.0517 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (ADMET) | = 18 % | Cytotoxicity against HEK293 cells assessed as cell viability at 100 uM after 24 hrs by MTT assay relative to control | ChEMBL. | 23374014 |
IC50 (binding) | > 100 uM | Inhibition of recombinant BACE1 (unknown origin) using FAM-SEVNLDAEFK-TAMRA as substrate incubated for 30 mins prior to substrate addition by fluorimetric analysis | ChEMBL. | 23374014 |
Inhibition (binding) | = 42.5 % | Inhibition of recombinant BACE1 (unknown origin) using FAM-SEVNLDAEFK-TAMRA as substrate at 100 uM incubated for 30 mins prior to substrate addition by fluorimetric analysis relative to control | ChEMBL. | 23374014 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.